Search
Sumario de resultados
TIpos de contenido
Fecha
-
CompanyTHYTECH S.L.
-
NewRocío Arroyo, CEO of Amadix, new president of AseBio
In the General Assembly of AseBio, new vice-presidents have also been elected: Carlos Buesa, CEO of Oryzon (First Vice-presidency); Cristina Nadal, Policy Executive Director of MSD Spain (Second Vice
-
Press releaseRocío Arroyo, CEO of Amadix, new president of AseBio
In the General Assembly of AseBio, new vice-presidents have also been elected: Carlos Buesa, CEO of Oryzon (First Vice-presidency); Cristina Nadal, Policy Executive Director of MSD Spain (Second Vice
-
NewVIVEbiotech achieves significant business growth in 2023 with increases in demand for its ...
Recent company sales grow by 70%, reflecting expanded capabilities and industry recognition of VIVEbiotech’s expertise in manufacturing lentiviruses, now used in in 70% of global ex-vivo CGT clinical
-
-
EventBio Equity Europe
-
-
EventLSX WORLD CONGRESS
-
-
EventSwiss Biotech Day
-
NewInnovation in mental health
Innovation has enabled breakthroughs such as recent drugs for Alzheimer's disease, the use of devices that stimulate brain function for the treatment of certain pathologies or Virtual Reality for post
-
NewBiotechnology is behind more than 40% of the active ingredients in medications included in...
Over the last 40 years, biotechnology has shaped the landscape of medicine, as evidenced by the fact that 69% of drugs in development are a result of biotechnological advancements.
-
Press release
Biotechnology is behind more than 40% of the active ingredients in medications included in...
The list, comprised of 268 drugs, is an important tool to support the EU's efforts to ensure the security of the supply chain and prevent shortages of critical medications. Over the last 40 years
-
New#NewAseBioMember | "AseBio is a key reference entity in the Spanish and European biotechno...
Meet BeCytes Biotechnologies, our new member. We talked with Estephan Arredondo Córdova, Technical Director
-
New#NewAllyAseBio | "AseBio represents the meeting place for all the companies in the biotech...
Meet JORI & ARMENGOL, our new ally. We talked to María Sanjuanbenito, ejecutiva de Cuentas.
-
AllyJORI & ARMENGOL CORREDURÍA DE SEGUROS Y REASEGUROS S.L.
JORI is a risk consultancy and insurance brokerage specialized in business insurance, with special expertise in Lifescience. We are partners in the I4CT (Insurance For Clinical Trials) platform
-
EventFood 4 Future
-
EventGerman Biotech Days
-
-
-
